SEOUL, July 18 (Yonhap) -- North Korea is developing a vaccine for the novel coronavirus on its own, Pyongyang's science research council said Saturday.
According to a report posted on Mirae, the website run by the North's State Commission of Science and Technology, its scientists are currently conducting clinical trials to develop a vaccine for COVID-19.
The report said the vaccine development is led by a medical biology institute under the North's Academy of Medical Science using angiotensin-converting enzyme 2 (ACE2).
North Korea claimed it has confirmed the immunogenicity and safety of its candidate vaccine through animal tests and that clinical trials have started from this month.
The communist state, which has yet to report a single virus case in the country, added that scientists are in discussions on conducting the third phase of clinical study.
North Korea said the bioengineering branch of the State Academy of Sciences is also conducting research for the development of the novel coronavirus vaccine.
Pundits here, however, cast doubt on North Korea's vaccine development considering its financial and medical situations.
N. Korea says month-old virus crisis under control, but skepticism lingers
Biden's trip highlights commitment to stronger alliance, hope for S. Korea's pivotal role in security: experts
N. Korean leader Kim ramps up nuclear threat, alludes to more aggressive doctrine
ICBM launch puts Yoon's N. Korea policy to test
Concerns grow over possible North Korean nuke test